[Lysergic acid monoethylamide, a new ergot derivatives with sedative effect in psychiatric medication].
D004565:Electroconvulsive Therapy; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives; D008237:Lysergic Acid; D001523:Mental Disorders / Q000628:therapy*; D011612:Psychosurgery; D011613:Psychotherapy
D004876:Ergot Alkaloids; D006993:Hypnotics and Sedatives; D008237:Lysergic Acid
ERGOT ALKALOIDS/therapeutic use; MENTAL DISORDERS/therapy
Lysergsäure-monoäthylamid (LAE), ein neuartiges Psychotikum mit sedativer Wirkung aus dem Mutterkorn.